Zhenchang Sun

694 citations
29 papers · 285 indexed · h-index 11
Topics
Lymphoma Diagnosis and Treatment (16 papers)Immune Cell Function and Interaction (8 papers)Chronic Lymphocytic Leukemia Research (3 papers)
Partner nations
ChinaUnited States

In The Last Decade

Zhenchang Sun

28 papers receiving 282 citations

Peers

Zhenchang Sun
Comparison fields: 5 of 65
  • Oncology 119
  • Pathology and Forensic Medicine 109
  • Molecular Biology 103
  • Cancer Research 58
  • Immunology 56
Replace Sung‐Hwan Park with:
Sung‐Hwan Park South Korea
Paulina Cybulska Canada
Jonathan Gong United States
Amr Hanbali United States
S. Nagel Germany
Pallawi Torka United States
Yi‐Hua Chen United States
Zhao Yin-nong China
М. В. Копп Russia
Zhenchang Sun relative to Sung‐Hwan Park South Korea Sung‐Hwan Park's profile →
Citations per field
00.5×4.4×
Sung‐Hwan Park · 1×
Citations per year

Countries citing papers authored by Zhenchang Sun

Since Specialization
Citations

This map shows the geographic impact of Zhenchang Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenchang Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenchang Sun more than expected).

Fields of papers citing papers by Zhenchang Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenchang Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenchang Sun. The network helps show where Zhenchang Sun may publish in the future.

Co-authorship network of co-authors of Zhenchang Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenchang Sun. A scholar is included among the top collaborators of Zhenchang Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenchang Sun. Zhenchang Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 17
2 7
3 1
4 6
5 3
6 11
7 2
8 6
9 10
10 5
11 19
12 18
13 12
14 14
15 8
16 17
17 0
18 15
19 9
20
[Experimental study of extract from Prunella vulgaris inducing B, T lymphoma cell apoptosis].
1

About Zhenchang Sun

Zhenchang Sun is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology, having authored 29 papers that have together received 285 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (16 papers), Immune Cell Function and Interaction (8 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (109 citations), Oncology (119 citations) and Cancer Research (58 citations). Zhenchang Sun has collaborated with scholars based in China and United States. Frequent co-authors include Xiaorui Fu, Zhaoming Li, Mingzhi Zhang, Yu Chang, Ling Li, Mingzhi Zhang, Feifei Nan, Xinhua Wang, Xudong Zhang and Jingjing Wu. Their work appears in journals such as Blood, Gut and Experimental Cell Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026